We are live on ! Find out more
SC

Sophrosyne Capital Portfolio holdings

AUM $11.5M
1-Year Est. Return 17.82%
This Fund
S&P 500
This Quarter Est. Return
+16.82%
1 Year Est. Return
+17.82%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$114M
AUM Growth
-$37M
Cap. Flow
-$42.8M
Cap. Flow %
-37.45%
Top 10 Hldgs %
55.88%
Holding
85
New
18
Increased
11
Reduced
34
Closed
19

Top Buys

Rank Stock Value
1
ARCT icon
Arcturus Therapeutics
ARCT
+$3.67M
2
FLNA
Filana Therapeutics
FLNA
+$3.22M
3
CYNI
CYAN INC COM
CYNI
+$2.12M
4
BEAT
BioTelemetry, Inc.
BEAT
+$2.04M
5
MNDT
Mandiant, Inc. Common Stock
MNDT
+$1.32M

Top Sells

Rank Stock Value
1
SIGA icon
SIGA Technologies
SIGA
+$4.46M
2
AVAV icon
AeroVironment
AVAV
+$4.42M
3
BDSI
BioDelivery Sciences International, Inc.
BDSI
+$4.02M
4
CALX icon
Calix
CALX
+$3.41M
5
SANW
S&W Seed Co
SANW
+$3.17M

Sector Composition

Rank Sector Weight
1 Healthcare 55.14%
2 Technology 27.01%
3 Communication Services 7.3%
4 Utilities 3.88%
5 Miscellaneous 3.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACFN
26
DELISTED
Acorn Energy Inc
ACFN
$1.33M 1.17%
+327,700
New +$1.22M
SQNS
27
Sequans Communications SA
SQNS
$44.3M
$1.31M 1.15%
6,552
-52
-0.8% -$11.2K
VSTM icon
28
Verastem
VSTM
$668M
$1.27M 1.11%
9,252
-3,056
-25% -$402K
SRL icon
29
Scully Royalty
SRL
$88.9M
$1.12M 0.98%
28,020
-28,980
-51% -$1.15M
LSTA icon
30
Lisata Therapeutics
LSTA
$16.4M
$963K 0.84%
941
+467
+99% +$462K
HNGR
31
DELISTED
Hanger Inc.
HNGR
$936K 0.82%
23,800
– –
TWTR
32
DELISTED
Twitter, Inc.
TWTR
$852K 0.75%
+13,400
New +$665K
CDZI icon
33
Cadiz
CDZI
$334M
$633K 0.55%
90,959
+46,662
+105% +$266K
ICAD
34
DELISTED
iCAD Inc
ICAD
$590K 0.52%
50,510
-145,500
-74% -$1.31M
UPI
35
DELISTED
UROPLASTY INC-NEW
UPI
$501K 0.44%
183,700
-45,000
-20% -$137K
SANW
36
DELISTED
S&W Seed Co
SANW
$493K 0.43%
3,741
-25,428
-87% -$3.17M
NSPR icon
37
InspireMD
NSPR
$41.6M
– –
0
– –
GCVRZ
38
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$423K 0.37%
1,238,998
+664,600
+116% +$803K
ACER
39
DELISTED
Acer Therapeutics Inc
ACER
$366K 0.32%
+2,400
New +$391K
ALT icon
40
Altimmune
ALT
$630M
$362K 0.32%
+647
New +$386K
SRPT icon
41
Sarepta Therapeutics
SRPT
$2.28B
$345K 0.3%
16,900
-72,500
-81% -$2.15M
ONCY
42
DELISTED
ONCOLYTICS BIOTECH INC
ONCY
$345K 0.3%
+222,900
New +$502K
LMNR icon
43
Limoneira
LMNR
$246M
$316K 0.28%
11,892
-21,900
-65% -$555K
SRNE
44
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$316K 0.28%
+38,900
New +$342K
SMSI icon
45
Smith Micro Software
SMSI
$16.5M
$289K 0.25%
1,221
-8,197
-87% -$1.41M
DMK
46
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$267K 0.23%
+600
New +$263K
RTK
47
DELISTED
Rentech, Inc.
RTK
$255K 0.22%
14,596
-3,110
-18% -$57K
ITRI icon
48
Itron
ITRI
$4.35B
$240K 0.21%
+5,800
New +$246K
GERN icon
49
Geron
GERN
$983M
$239K 0.21%
+53,429
New +$229K
VWTR
50
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
$224K 0.2%
9,700
+5,500
+131% +$129K
1
2
3 4

Similar funds

SFM
Socratic Fund Management Short Hills, New Jersey $12M AUM 39.3% 1-Year Est. Return
IACGFA
IDG-Accel China Growth Fund Associates Central, Hong Kong $13.2M AUM 31.6% 1-Year Est. Return
LS
Lupo Securities Chicago, Illinois $13.3M AUM 1.59% 1-Year Est. Return
NGPI
N.G. Partners II Palo Alto, California $9.65M AUM 70.44% 1-Year Est. Return
AP
AGTC Partners Cambridge, Massachusetts $13.6M AUM 15.62% 1-Year Est. Return
GRP
Geologic Resource Partners Boston, Massachusetts $9.22M AUM 48.14% 1-Year Est. Return
NVPV
Norwest Venture Partners VIII Palo Alto, California $9.22M AUM
AC
Amiya Capital London, United Kingdom $14.3M AUM 4.61% 1-Year Est. Return

Sophrosyne Capital's Q4 2013 Portfolio in Review

As of Q4 2013, Sophrosyne Capital held 85 positions worth $114M, down 24% from $151M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Sophrosyne Capital withdrew a net $42.8M in Q4 2013, closing 19 positions and reducing 34 holdings. Its most notable exit was SIGA Technologies, an estimated $4.46M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 55% of assets, up from 50% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Sophrosyne Capital opened a new position in CYAN INC COM worth $1.88M.

  • Sophrosyne Capital's largest Q4 2013 buy was CYAN INC COM: 354,699 shares worth $1.88M.
  • Sophrosyne Capital added most to Arcturus Therapeutics in Q4 2013, an estimated $3.67M increase.
  • Sophrosyne Capital's biggest Q4 2013 reduction was AeroVironment, cutting an estimated $4.42M.
  • Sophrosyne Capital fully exited SIGA Technologies in Q4 2013, selling an estimated $4.46M.
  • Sophrosyne Capital's ten largest holdings make up 56% of its $114M portfolio in Q4 2013.
  • Sophrosyne Capital opened 18 new positions and closed 19 in Q4 2013.
  • Sophrosyne Capital's portfolio value fell 24% quarter-over-quarter to $114M.

Based on Sophrosyne Capital's 13F filing for Q4 2013, filed 13 Feb 2014.